Glyoxal fixation: an immunohistochemistry assay evaluation

J Histotechnol. 2022 Jun;45(2):77-84. doi: 10.1080/01478885.2021.1996125. Epub 2021 Dec 8.

Abstract

Analysis of surgical pathology specimens by histological techniques including immunohistochemistry (IHC) assays is a mainstay of disease diagnosis in humans. Neutral buffered formalin (NBF) is currently the primary fixative used, but its use is not without risks due to toxicity and carcinogenicity. Several glyoxal-based fixatives have been commercially produced, are considered safer alternatives to NBF, and produce histochemical staining results comparable to that of tissues fixed in NBF. However, previous studies evaluating IHC assay results in tissues fixed in NBF and glyoxal solutions have indicated mixed results. This study demonstrated that while tissues fixed in NBF were slightly superior to tissues fixed in glyoxal solutions among the 34 antibodies assayed with IHC, all fixative solutions produced results compatible for use in an anatomic pathology laboratory.

Keywords: FFPE; Glyoxal; IHC; NBF; fixative; formalin; immunohistochemistry.

MeSH terms

  • Fixatives / pharmacology
  • Formaldehyde* / pharmacology
  • Glyoxal* / pharmacology
  • Humans
  • Immunohistochemistry
  • Tissue Fixation / methods

Substances

  • Fixatives
  • Formaldehyde
  • Glyoxal